
Sign up to save your podcasts
Or


Joe and Eric speak with Charley Hooper, author of the book Should the FDA Reject Itself? Part one of their discussion explores the likely impact of the Inflation Reduction Act and its drug pricing provisions, which include: overall drug production, the total impact on inflation, as well as the irony of prices actually going up as a result. *Episode aired Oct 26, 2022*
By Stay On Course Studios5
1212 ratings
Joe and Eric speak with Charley Hooper, author of the book Should the FDA Reject Itself? Part one of their discussion explores the likely impact of the Inflation Reduction Act and its drug pricing provisions, which include: overall drug production, the total impact on inflation, as well as the irony of prices actually going up as a result. *Episode aired Oct 26, 2022*

153,989 Listeners

4,270 Listeners

4,909 Listeners

707 Listeners

6,623 Listeners

337 Listeners

3,357 Listeners

34 Listeners

40,434 Listeners

6,298 Listeners

718 Listeners

453 Listeners

8,447 Listeners

16,982 Listeners

1,480 Listeners